Cover Image

Studies on serum nitric oxide levels in subjects with high bilirubin value in comparison of normal healthy control subjects

Ramesh Kumar*, Ritika Jain

Abstract


Bilirubin is excreted in bile and urine, and elevated levels may indicate certain diseases. Serum bilirubin are inversely related to risk of certain heart diseases. Since nitric oxide (NO) is produced by three types of Nitric Oxide Synthases (NOSs), rapid changes in stable oxidized metabolites (nitrite and nitrate) in the tissues and blood should be represented by the amount of stable forms in serum and may reflect changes in the body. Therefore, the aim of this study was to evaluate the correlation between nitric oxide (nitrite & nitrate) production and bilirubin levels in serum. The serum samples were collected from individuals with high levels of bilirubin and normal range controls. Nitrite was measured by a Griess reaction while nitrate was measured using the enzymatic one step assay with nitrate reductase. The total 36 samples (18 normal range (N) and 18 high bilirubin values (H)) were evaluated for the NO levels. The age group varies from 4-70 & 5-65 for normal & high levels of bilirubin, respectively. The levels of bilirubin in the normal range & high values varies from 0.81-0.98 (mean=0.88+0.01) & 1.12-20.18 (mean=5.96+2.07), respectively. When the nitrite (14.48+1.05μM versus 13.96+0.96μM, P>0.05) and nitrate (25.85+2.04μM versus 25.85+1.53μM, P>0.05) levels were compared between these groups no significant differences were observed. Results of this study reveal that there is no correlation between nitric oxide production and the serum bilirubin levels.

Keywords


Bilirubin; Nitric Oxide; Nitrite,;Nitrate.

Full Text:

PDF

References


Rodgers, P. A. and Stevenson, D. K. Developmental biology of heme oxygenase. Clin. Perinatol. 17: 275-291, 1990.

Maines M. D, Heme oxygenase: function, multiplicity, regulatory mechanisms and clinical applications. FASEB J 1988; 2: 2557-2568.

Baran˜ano D. E, Rao M, Ferris C. D, Snyder S. H. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 2002; 99: 16093–8.

Clark J. E, Foresti R, Green C. J, Motterlini R. Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J 2000; 348:615–9.

McDonagh A. F. Is bilirubin good for you? Clin Perinatol 1990; 17:359–69.

Stocker R, Yamamoto Y, McDonagh A. F, Glazer A. N, Ames B. N. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235:1043–6.

Sedlak T. W, Snyder SH. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 2004; 113:1776–82.

Choi A. M, Alam J. Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 1996; 15: 9–19.

Braudeau C, Bouchet D, Tesson L et al., Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther 2004; 11: 701–710.

Hayashi S, Takamiya R, Yamaguchi T et al., Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: Role of bilirubin generated by the enzyme. Circ Res 1999; 85: 663–671.

Foresti R, Sarathchandra P, Clark J. E, Green C. J, Motterlini R. Peroxynitrite induces haem oxygenase-1 in vascular endothelial cells: A link to apoptosis. Biochem J 1999; 339(Pt 3):729–736.

Harstsfield C. L, Alam J, Cook J. L, Choi AMK. Regulation of hemeoxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. Am J Physiol 1997; 273: L989-L988.

Umar S, van der Laarse A. Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol Cell Biochem. 2010; 333:191-201.

Krüger M, LinkeWA. Titin-based mechanical signalling in normal and failing myocardium. J Mol Cell Cardiol. 2009; 46:490-498.

Sessa W. C. Molecular control of blood flow and angiogenesis: role of nitric oxide. J ThrombHaemost. 2009; 7:35-37.

Krauss H, Jablecka A, Sosnowski P, et al., Influence of L-arginine on the nitric oxide concentration and level of oxidative stress during ischemia-reperfusion injury in a rat model. Int J ClinPharmacolTher. 2009; 47:533-538.

Kanwar J. R, Kanwar R. K, Burrow H, et al., Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr Med Chem. 2009; 16:2373-2394.

Gonzalez-Gay M. A, Garcia-Unzueta M. T, Berja A, et al., Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis. ClinExpRheumatol. 2009; 27:452-458.

Brenol C. V, Chies J. A, Brenol J. C, et al., Endothelial nitric oxide synthase T-786C polymorphism in rheumatoid arthritis: association with extraarticular manifestations. ClinRheumatol. 2009; 28:201-205.

van den Hove M. F, Stoenoiu M. S, Croizet K, et al., Nitric oxide is involved in interleukin-1alpha-induced cytotoxicity in polarised human thyrocytes. J Endocrinol. 2002; 173:177-185.

Förstermann U, Closs E. I, Pollock J. S, et al., Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.Hypertension. 1994; 23:1121-1131.

Matsubara T, Ishibashi T, Hori T, et al., Association between coronary endothelial dysfunction and local inflammation of atherosclerotic coronary arteries.Mol Cell Biochem.2003;249:67-73.

Ekmekçi H, Işler I, Sönmez H, et al., Comparison of platelet fibronectin, ADP-induced platelet aggregation and serum total nitric oxide (NOx) levels in angiographically determined coronary artery disease.Thromb Res.2006;117:249-254.

Akarasereenont P, Nuamchit T, Thaworn A, et al., Serum nitric oxide levels in patients with coronary artery disease.J Med AssocThai.2001;84:S730-739.

Kawashima H, Inage Y, Ogihara M,et al., Serum and cerebrospinal fluid nitrite/nitrate levels in patients with rotavirus gastroenteritis induced convulsion. Life Sci. 2004;74:1397-1405.

Oekonomaki E, Notas G, Mouzas IA, et al., Binge drinking and nitric oxide metabolites in chronic liver disease.Alcohol. 2004;39:106-109.

Kamiya Y, Ohta Y, Imai Y, et al., A criticalrole of gastric mucosal ascorbic acid in the progression of acute gastric mucosal lesions induced by compound 48/80 in rats. World J Gastroenterol.2005;11:1324-1332.

Loukovaara M. J, Loukovaara S, Leinonen PJ, et al., Endothelium-derived nitric oxide metabolites and soluble intercellular adhesion molecule-1 in diabetic and normal pregnancies. Eur J ObstetGynecolReprod Biol. 2005;118:160-165.

Chou T. C, Yen M. H, Li C. Y, et al., Alterations of nitric oxide synthase expression with aging and hypertension in rats.Hypertension.1998;31:643-648.

terSteege J. C, Koster-Kamphuis L, van Straaten E. A, et al., Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic Biol Med.1998a; 25:953-963.

terSteege J. C, van de Ven M. W, Forget P. P, et al., The role of endogenous IFN-gamma, TNF-alpha and IL-10 in LPS-induced nitric oxide release in a mouse model.Cytokine. 1998b; 10:115-123.

Choi J. W. Nitric oxide production is increased in patients with rheumatoid arthritis but does not correlate with laboratory parameters of disease activity.ClinChimActa.2003;336:83-87.

Kumar R, Pai K, Sundar S. Reactive oxygen intermediates, nitrite and IFN-gamma in Indian visceral leishmaniasis. Clin Exp Immunol. 2001; 124(2): 262-5.

Bories P. N, Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitratereductase. Clin Chem. 1995; 41(6 Pt 1): 904-7.

Vitek L, Jirsa M, Brodanova M, et al., Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis.2002;160:449–456.

Shimomura H, Ogawa H, Takazoe K, et al., Comparison of urinary biopyrrin levels in acute myocardial infarction (after reperfusion therapy) versus stable angina pectoris and their usefulness in predicting subsequent cardiac events. Am J Cardiol. 2002; 90:108–111.

Morita Y, Takahashi H, Kamihata H, Yamamoto Y, Hara K, Iwasaka T. Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases after spasm provocation tests in patients with coronary spastic angina. Int J Cardiol. 2001; 80:243–250.

Hokamaki J, Kawano H, Yoshimura M, et al., Urinary biopyrrins levels are elevated in relation to severity of heart failure. J Am Coll Cardiol. 2004; 43:1880–1885.

Tsukahara H, Haruta T, Todoroki Y, et al., Oxidant and antioxidant activities in childhood meningitis. Life Sci. 2002; 71:2797–2806.

Kozaki N, Shimizu S, Chijiiwa K, et al., Bilirubin as an anti-oxidant for surgical stress: a preliminary report of bilirubin oxidative metabolites. HPB Surg. 1999; 11:241–248.

Tsujinaka T, Fujita J, Morimoto T, et al., Increased urinary excretion of bilirubin metabolites in association with hyperbilirubinemia after esophagectomy. Surg Today. 1998; 28:1119–1123.

Yamaguchi T, Shioji I, Sugimoto A, Yamaoka M. Psychological stress increases bilirubin metabolites in human urine. Biochem Biophys Res Commun. 2002; 293:517–520.

Yoshida R, Ogawa Y, Shioji I, et al., Urinary 8-oxo-7, 8-dihydro-2_-deoxyguanosine and biopyrrins levels among construction workers with asbestos exposure history. Ind Health. 2001; 39:186–188.

Kimpara T, Takeda A, Yamaguchi T, et al., Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer’s disease. Neurobiol Aging. 2000; 21:551–554.

Vitek L, Kraslova I, Muchova L, Dudkova L, Novotny L, Yamaguchi T. Urinary excretion of oxidative metabolites of bilirubin in subjects with Gilbert syndrome [abstract]. FASEB J. 2004;18: A1189.

Zucker S. D, Qin X. F, Yu F, Goessling W. Inhibition of breast cancer cell proliferation by unconjugated bilirubin is associated with enhanced expression of apolipoprotein D and increased nuclear translocation of transcription factor NF-kappa B [abstract]. Hepatology. 1999; 30:498A.

Keshavan P, Schwemberger S. J, Smith D. L, Babcock G. F, Zucker S. D. Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int J Cancer. 2004; 112:433–445.

Zucker S. D, Horn P. S, Sherman K. E. Serum bilirubin levels in the U. S. population: gender effect and inverse correlation with colorectal cancer. Hepatology. 2004; 40:827–835.

Guillemette C, Millikan RC, Newman B, Housman DE. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res. 2000; 60:950–956.

Adegoke O. J, Shu X. O, Gao Y. T, et al., Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer. Breast Cancer Res Treat. 2004; 85:239–245.

Guillemette C, De Vivo I, Hankinson S. E, et al., Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol Biomarkers Prev. 2001; 10:711–714.

Cerne D, Ledinski G, Kager G, Greilberger J, Wang X. S, Jurgens G. Comparison of laboratory parameters as risk factors for the presence and the extent of coronary or carotid atherosclerosis: the significance of apolipoprotein B to apolipoprotein all ratio. Clin Chem Lab Med. 2000; 38:529–538.

Kangas E, Teittinen K, Vilkko P, Utriainen S. Bilirubin and peripheral vascular disease. Br J Surg. 1999;86(5):713.

Ko G. T, Chan J. C, Woo J, et al., Serum bilirubin and cardiovascular risk factors in a Chinese population. J Cardiovasc Risk. 1996; 3:459–463.

Papadakis J. A, Ganotakis E. S, Jagroop I. A, Mikhailidis D. P, Winder A. F. Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia. Am J Hypertens. 1999; 12:673–681.

Vitek L, Novotny L, Muchova L, Tesar V, Schwertner H. Decreased levels of serum bilirubin as a risk factor in lupus nephropathy. J Am Soc Nephrol. 2003; 14:381A–382A.

Oren D. A, Desan P. H, Boutros N, Anand A, Charney DS. Effects of light on low nocturnal bilirubin in winter depression: a preliminary report. Biol Psychiatry. 2002; 51:422–425.

Schwertner H. A, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 2008 May;198(1):1-11.

Horsfall L. J, Nazareth I, Petersen I. Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation 2012 November 27;126(22):2556-64.

Horsfall L. J, Rait G, Walters K et al., Serum bilirubin and risk of respiratory disease and death. JAMA 2011 February 16;305(7):691-7.

Inoguchi T, Sasaki S, Kobayashi K, Takayanagi R, Yamada T. Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA 2007 September 26;298(12):1398-400.

McCarty M. F. ''Iatrogenic Gilbert syndrome''--a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med Hypotheses 2007;69(5):974-94.

Chan K. H, O'Connell R. L, Sullivan D. R et al., Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 2013 January 17.

Cheriyath P, Gorrepati VS, Peters I et al., High Total Bilirubin as a Protective Factor for Diabetes Mellitus: An Analysis of NHANES Data from 1. J Clin Med Res 2010 October 11;2(5):201-6.

Fischman D, Valluri A, Gorrepati V. S, Murphy M. E, Peters I, Cheriyath P. Bilirubin as a Protective Factor for Rheumatoid Arthritis: An NHANES Study of 2. J Clin Med Res 2010 December 11;2(6):256-60.

Lanone S, Bloc S, Foresti R et al., Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 2005 November;19(13):1890-2.

Jiang F, Roberts S. J, Datla S, Dusting G. J. NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension 2006 November;48(5):950-7.

Matsumoto H, Ishikawa K, Itabe H, Maruyama Y. Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction. Mol Cell Biochem 2006 October;291(1-2):21-8.

Datla S. R, Dusting G. J, Mori T. A, Taylor C. J, Croft K. D, Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 2007 October;50(4):636-42.

Basuroy S, Bhattacharya S, Leffler C. W, Parfenova H. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am J Physiol Cell Physiol 2009 March;296(3):C422-C432.

Wang H, Lee S. S, Dell'Agnello C et al., Bilirubin can induce tolerance to islet al., lografts. Endocrinology 2006 February;147(2):762-8.

Rocuts F, Zhang X, Yan J et al., Bilirubin promotes de novo generation of T regulatory cells. Cell Transplant 2010;19(4):443-51.

McCarty M. F. Clinical potential of phycocyanobilin for induction of T regulatory cells in the management of inflammatory disorders. Med Hypotheses 2011 December;77(6):1031-3.

Andersson C, Weeke P, Fosbol E. L et al., Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial. Metabolism 2009 August;58(8):1109-15.

Abd El-Azem M. Ali, Atwa M., Gharib N. A, and El- Said K. Assessment of endothelial function in patients with portal hypertension. Egyptian Journal of Surgery 2000: 19(3): 258-263.




DOI: http://dx.doi.org/10.21746/ijbio.2016.03.004

Refbacks

  • There are currently no refbacks.




Copyright (c) 2016 International Journal of Bioassays

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.